CDKN2A mutation + TP53 mutation
|
Small Cell Lung Cancer
|
CDKN2A mutation + TP53 mutation
|
Small Cell Lung Cancer
|
AZD1775 Sensitive: C2 – Inclusion Criteria
|
AZD1775 Sensitive: C2 – Inclusion Criteria
|
CDKN2A mutation + TP53 mutation
|
NSCLC
|
CDKN2A mutation + TP53 mutation
|
NSCLC
|
Immunotherapy Sensitive: C3 – Early Trials
|
Immunotherapy Sensitive: C3 – Early Trials
|